Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(265)

64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark

64. Tech-driven acceleration in clinical trials, Benjamine Liu, Co-founder and CEO, TrialSpark

Benjamine Liu is the co-founder and CEO of TrialSpark, a technology company that is reimagining drug development. Benjamine received his DPhil at Oxford as a Rhodes Scholar, conducting his work with ...

14 Heinä 202127min

63. Building a leader in infectious diseases, Ankit Mahadevia, President and CEO, Spero Therapeutics

63. Building a leader in infectious diseases, Ankit Mahadevia, President and CEO, Spero Therapeutics

Ankit Mahadevia is the CEO of Spero Therapeutics and a member of the Board of Directors. He was formerly a Venture Partner in the life sciences group at Atlas Venture, located in Cambridge, MA. In tha...

7 Heinä 202138min

62. Tackling autoimmune and allergic disease, Jonathan Rigby, Group CEO, Revolo Biotherapeutics

62. Tackling autoimmune and allergic disease, Jonathan Rigby, Group CEO, Revolo Biotherapeutics

Jonathan Rigby is an experienced CEO with three decades of experience creating value and opportunities for companies in the pharmaceutical, biotech and drug delivery technology industry. He currently ...

23 Kesä 202125min

61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences

61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences

Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and a member of our Board of Directors since September 2015. Dr. Gill also has served on the board of directors of R...

16 Kesä 202140min

60. BIOS Edition: Investing in biotech and healthcare, Yizhen Dong, Partner, Global Founders Capital

60. BIOS Edition: Investing in biotech and healthcare, Yizhen Dong, Partner, Global Founders Capital

Yizhen is passionate about investing in and working with persevering entrepreneurs who want to change the world, especially in healthcare and biotech. Yizhen focuses on early stage investments in fron...

9 Kesä 202128min

59. Targeted cancer therapies using engineered viruses, Alice Bexon, Chief Medical Officer, Vyriad

59. Targeted cancer therapies using engineered viruses, Alice Bexon, Chief Medical Officer, Vyriad

Dr. Bexon brings to Vyriad more than 20 years of management experience in clinical development of biopharmaceuticals, including management of multi-site clinical trials and FDA approval of lead assets...

19 Touko 202119min

58. End game vaccine for COVID-19, Marty Moore, Cofounder and CEO, Meissa Vaccines

58. End game vaccine for COVID-19, Marty Moore, Cofounder and CEO, Meissa Vaccines

Martin (Marty) is a cofounder and chief executive officer of Meissa Vaccines. Prior to cofounding Meissa, Marty was an Associate Professor at Emory University and director of the Emory Children’s Cent...

12 Touko 202124min

57. Next frontier in schizophrenia and mental health, Andrew Miller, Founder and COO, Karuna

57. Next frontier in schizophrenia and mental health, Andrew Miller, Founder and COO, Karuna

Dr. Miller is a Founder and the Chief Operating Officer of Karuna Therapeutics. Dr. Miller is the lead inventor of Karuna’s KarXT platform and served as CEO of Karuna from 2016-2018. He served as a me...

5 Touko 202127min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
tiedekulma-podcast
rss-hereilla
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-duodecim-lehti
rss-tiedetta-vai-tarinaa
docemilia
hippokrateen-vastaanotolla
rss-bios-podcast
rss-radplus
radio-antro
rss-lihavuudesta-podcast
rss-politiikasta-podcast
rss-ranskaa-raakana